Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) Shares Outstanding (Diluted Average) (2020 - 2025)

Beauty Health (SKIN) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $126.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 2.28% to $126.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $126.9 million, a 2.28% increase, with the full-year FY2024 number at $142.5 million, up 8.21% from a year prior.
  • Shares Outstanding (Diluted Average) was $126.9 million for Q3 2025 at Beauty Health, down from $140.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $152.7 million in Q1 2022 to a low of $63.8 million in Q2 2021.
  • A 5-year average of $132.1 million and a median of $132.8 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 197.77% in 2021, then dropped 13.43% in 2025.
  • Beauty Health's Shares Outstanding (Diluted Average) stood at $102.1 million in 2021, then soared by 45.43% to $148.5 million in 2022, then fell by 11.33% to $131.7 million in 2023, then grew by 8.21% to $142.5 million in 2024, then fell by 10.95% to $126.9 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Shares Outstanding (Diluted Average) are $126.9 million (Q3 2025), $140.3 million (Q2 2025), and $125.1 million (Q1 2025).